Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
2976
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.03M | ﹤0.01% |
251,539
+167,682
| +200% | +$3.23M |
|
|
CSR
2977
Centerspace
CSR
$952M
| $3.02M | ﹤0.01% |
54,978
-92,594
| -63% | -$6.63M |
|
2978
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$39.1M
| $3.02M | ﹤0.01% |
+143,724
| New | +$3.38M |
|
|
SFT
2979
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $3.02M | ﹤0.01% |
+30,000
| New | +$3M |
|
2980
Pitney Bowes
PBI
$2.39B
| $3.02M | ﹤0.01% |
1,478,419
+631,020
| +74% | +$2.16M |
|
|
JOBS
2981
DELISTED
51job Inc
JOBS
| $3.02M | ﹤0.01% |
49,123
-24,626
| -33% | -$1.87M |
|
2982
Moelis & Co
MC
$4.94B
| $3.01M | ﹤0.01% |
107,237
-158,029
| -60% | -$5.18M |
|
|
COUP
2983
CALL
DELISTED
Coupa Software Incorporated
COUP
| $3M | ﹤0.01% |
21,500
| – | – |
|
|
DHC
2984
Diversified Healthcare Trust
DHC
$2.14B
| $3M | ﹤0.01% |
826,049
-488,876
| -37% | -$3.21M |
|
|
NBIS
2985
CALL
Nebius Group N.V.
NBIS
$47.7B
| $2.98M | ﹤0.01% |
87,600
+59,000
| +206% | +$2.43M |
|
|
SPWR
2986
DELISTED
SunPower Corporation Common Stock
SPWR
| $2.98M | ﹤0.01% |
897,717
+425,049
| +90% | +$2.24M |
|
2987
OraSure Technologies
OSUR
$279M
| $2.98M | ﹤0.01% |
276,875
+113,676
| +70% | +$813K |
|
2988
PUT
Illumina
ILMN
$28.4B
| $2.98M | ﹤0.01% |
11,205
+3,701
| +49% | +$1.03M |
|
2989
Invesco S&P 500 High Beta ETF
SPHB
$1.02B
| $2.97M | ﹤0.01% |
101,799
+21,058
| +26% | +$868K |
|
2990
Rush Enterprises Class A
RUSHA
$6.22B
| $2.97M | ﹤0.01% |
209,219
-113,964
| -35% | -$2.06M |
|
|
TEN
2991
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.96M | ﹤0.01% |
823,609
-724,624
| -47% | -$6.08M |
|
2992
Douglas Dynamics
PLOW
$1.02B
| $2.96M | ﹤0.01% |
83,430
+21,708
| +35% | +$1.02M |
|
2993
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.08B
| $2.96M | ﹤0.01% |
50,000
| – | – |
|
2994
PUT
Align Technology
ALGN
$12.3B
| $2.96M | ﹤0.01% |
+17,000
| New | +$4.07M |
|
2995
Groupon
GRPN
$1.02B
| $2.95M | ﹤0.01% |
150,448
+5,815
| +4% | +$229K |
|
|
LBAI
2996
DELISTED
Lakeland Bancorp Inc
LBAI
| $2.95M | ﹤0.01% |
272,625
-31,061
| -10% | -$460K |
|
|
MFA
2997
MFA Financial
MFA
$933M
| $2.94M | ﹤0.01% |
474,395
-1,978,710
| -81% | -$52.7M |
|
2998
PUT
Zimmer Biomet
ZBH
$18.4B
| $2.94M | ﹤0.01% |
+29,973
| New | +$3.93M |
|
2999
Virtus Biotech Clinical Trials ETF
BBC
$49.9M
| $2.93M | ﹤0.01% |
100,000
| – | – |
|
3000
BioCryst Pharmaceuticals
BCRX
$2.4B
| $2.93M | ﹤0.01% |
1,464,540
+341,261
| +30% | +$940K |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.